BC Innovations | Apr 10, 2019
Distillery Therapeutics

Imidazopyrimidine-based inhibitor of Leishmania proteasome identified to treat visceral leishmaniasis

DISEASE CATEGORY: Infectious disease INDICATION: Leishmaniasis Cell culture, in vitro , mouse, rat and dog studies identified an imidazopyrimidine-based inhibitor of Leishmania proteasome that could help treat visceral leishmaniasis. Chemical synthesis and screening in L. donovani...
Items per page:
1 - 1 of 1